Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SANUWAVE HealthSNWV -5.92%29 PS Ratio is 0.92 as of Aug. 21, 2026, which is 88% below its 10-year median of 7.91. GuruFocus rates SNWV with a GF Score™ of 29/100 and a GF Value™ of $12.85 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 803 Medical Devices & Instruments companies, SANUWAVE Health ranks better than 80.82% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, SANUWAVE Health's share price is $4.61.
SANUWAVE Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $4.99. Hence, SANUWAVE Health's PS Ratio for today is 0.92.
Good Sign:
SANUWAVE Health Inc stock PS Ratio (=0.98) is close to 1-year low of 0.95.
The historical rank and industry rank for SANUWAVE Health's PS Ratio or its related term are showing as below:
SNWV'
s PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 7.91 Max: 97.88
Current: 0.92
During the past 13 years, SANUWAVE Health's highest PS Ratio was 97.88. The lowest was 0.05. And the median was 7.91.
SNWV's PS Ratio is ranked better than 80.82% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.96
vs SNWV: 0.92
SANUWAVE Health Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of SANUWAVE Health was -21.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -24.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.50% per year.
During the past 13 years, SANUWAVE Health's highest 3-Year average Revenue per Share Growth Rate was 82.00% per year. The lowest was -32.70% per year. And the median was -20.70% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
SANUWAVE Health PS Ratio Related Terms
SANUWAVE Health PS Ratio Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SANUWAVE Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
SANUWAVE Health's Share Price of today is $4.61. SANUWAVE Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
SANUWAVE Health (SNWV) has a PS Ratio of 0.92 as of Aug. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SANUWAVE Health and its competitors. This is 88% below median its historical median of 7.91. Over the past decade, SANUWAVE Health's PS Ratio has ranged from 0.05 to 97.88. According to the industry distribution chart, SANUWAVE Health ranks #154 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 19.2%.
Is SANUWAVE Health's PS Ratio too high?
SANUWAVE Health's current PS Ratio of 0.92 is 88% below median its 10-year median of 7.91. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 97.88. The Medical Devices & Instruments industry median PS Ratio is 2.96. SANUWAVE Health's value of 0.92 is 68.9% below this industry median. Based on the distribution chart, SANUWAVE Health ranks #154 out of 803 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SANUWAVE Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's PS Ratio compare to SRTS and COCH?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #154 out of 803 companies for PS Ratio. This places SANUWAVE Health in the top 19% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.96. SANUWAVE Health's value of 0.92 is 68.9% below this benchmark. Historically, SANUWAVE Health's own PS Ratio has ranged from 0.05 to 97.88 over the past decade. While the company's 10-year median is 7.91 vs. the industry median of 2.96, SANUWAVE Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.96, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current PS Ratio of 0.92 is 68.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on SANUWAVE Health and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current PS Ratio is 0.92, which is 88% below median its own 10-year median of 7.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $12.85, compared to a current price of $4.61 — trading 64.1% below its estimated fair value. The current PS Ratio is 0.92, which is 88% below median its 10-year median of 7.91 and 68.9% below the Medical Devices & Instruments industry median of 2.96. SANUWAVE Health's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current PS Ratio is 0.92 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $4.61 is trading 64.1% below its estimated GF Value™ of $12.85.
GuruFocus considers SANUWAVE Health to be Possible Value Trap.
Key valuation signals for SNWV:
PS Ratio: 0.92 (88% below median its 10-year median of 7.91)
GF Value™: $12.85 vs. price of $4.61 (64.1% below fair value)
Industry Position: 68.9% below the Medical Devices & Instruments median (#154 of 803)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
29GF Score
Get the complete analysis for SNWV
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
